Can taking Premphase increase my risk of ovarian cancer?

Advertisement
Advertisement
Several studies suggest that women who take combination replacement therapy such as Premphase may have an increased risk of ovarian cancer. More research is needed to confirm a direct link between combination hormone replacement therapy and ovarian cancer. In the meantime, talk to your doctor regularly about your health status, risk factors and hormone replacement therapy.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.